2 ML anifrolumab-fnia 150 MG/ML Injection

RxCUI: 2565280
RxNorm name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Display name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Full name: 2 ML anifrolumab-fnia 150 MG/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761123	Saphnelo	anifrolumab-fnia	351(a)	Rx	2026-06-01
761451	Saphnelo	anifrolumab-fnia	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SAPHNELO	ANIFROLUMAB-FNIA	AstraZeneca Pharmaceuticals LP	d6203302-2128-41a7-b0b4-0e6c0704d4dc	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 2565280

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d6203302-2128-41a7-b0b4-0e6c0704d4dc	2 ML anifrolumab-fnia 150 MG/ML Injection	SCD	15	These highlights do not include all the information needed to use SAPHNELO ® safely and effectively. See full prescribing information for SAPHNELO. SAPHNELO (anifrolumab-fnia) injection, for intravenous, or subcutaneous use Initial U.S. Approval: 2021	20260424
d6203302-2128-41a7-b0b4-0e6c0704d4dc	anifrolumab-fnia 300 MG per 2 ML Injection	SY	15	These highlights do not include all the information needed to use SAPHNELO ® safely and effectively. See full prescribing information for SAPHNELO. SAPHNELO (anifrolumab-fnia) injection, for intravenous, or subcutaneous use Initial U.S. Approval: 2021	20260424
d6203302-2128-41a7-b0b4-0e6c0704d4dc	anifrolumab-fnia 300 MG in 2 ML Injection	PSN	15	These highlights do not include all the information needed to use SAPHNELO ® safely and effectively. See full prescribing information for SAPHNELO. SAPHNELO (anifrolumab-fnia) injection, for intravenous, or subcutaneous use Initial U.S. Approval: 2021	20260424